Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation

Huimin Deng,Siqi Yang,Yucheng Zhang,Kai Qian,Zhaohui Zhang,Yangyang Liu,Ye Wang,Yang Bai,Hongying Fan,Xinmei Zhao,Fachao Zhi

DOI: https://doi.org/10.3389/fmicb.2018.02976

IF: 5.2

2018-12-21

Frontiers in Microbiology

Abstract:<i>Clostridium difficile</i> is currently the leading cause of nosocomial infection. Antibiotics remain the first-line therapy for <i>C. difficile</i>-associated diseases (CDAD), despite the risks of resistance promotion and further gut microbiota perturbation. Notably, the abundance of <i>Bacteroides fragilis</i> was reported to be significantly decreased in CDAD patients. This study aimed to clarify the prophylactic effects of <i>B. fragilis</i> strain ZY-312 in a mouse model of <i>C. difficile</i> infection (CDI). The CDI mouse model was successfully created using <i>C. difficile</i> strain VPI 10463 spores, as confirmed by lethal diarrhea (12.5% survival rate), serious gut barrier disruption, and microbiota disruption. CDI model mice prophylactically treated with <i>B. fragilis</i> exhibited significantly higher survival rates (100% in low dosage group, 87.5% in high dosage group) and improved clinical manifestations. Histopathological analysis of colon and cecum tissue samples revealed an intact gut barrier with strong ZO-1 and Muc-2 expression. The bacterial diversity and relative abundance of gut microbiota were significantly improved. Interestingly, the relative abundance of <i>Akkermansia muciniphila</i> was positively correlated with <i>B. fragilis</i> treatment. <i>In vitro</i> experiments showed that <i>B. fragilis</i> inhibited <i>C. difficile</i> adherence, and attenuated the decrease in CDI-induced transepithelial electrical resistance, ZO-1 and MUC-2 loss, and apoptosis, suggesting that <i>B. fragilis</i> protected against CDI possibly by resisting pathogen colonization and improving gut barrier integrity and functions. In summary, <i>B. fragilis</i> exerted protective effects on a CDI mouse model by modulating gut microbiota and alleviating barrier destruction, thereby relieving epithelial stress and pathogenic colitis triggered by <i>C. difficile</i>. This study provides an alternative preventative measure for CDI and lays the foundations for further investigations of the relationships among opportunistic pathogens, commensal microbiota, and the gut barrier.

microbiology